Literature DB >> 22091161

(Z)-Ethyl 2-cyano-2-{2-[5,6-dimethyl-4-(thio-phen-2-yl)-1H-pyrazolo-[3,4-b]pyridin-3-yl]hydrazinylidene}acetate.

Hoong-Kun Fun, Madhukar Hemamalini, Hatem A Abdel-Aziz, Tarek Aboul-Fadl.   

Abstract

In the title compound, C(17)H(16)N(6)O(2)S, an intra-molecular N-H⋯O inter-action generates an S(6) ring. The pyridine ring makes a dihedral angle of 71.38 (11)° with the thio-phene ring. In the crystal, mol-ecules are linked by a pair of N-H⋯N hydrogen bonds, forming an inversion dimer. The dimers are stacked in columns along the b axis through weak inter-molecular C-H⋯N hydrogen bonds.

Entities:  

Year:  2011        PMID: 22091161      PMCID: PMC3213584          DOI: 10.1107/S1600536811028911

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For applications of pyrazole derivatives, see: Casas et al. (2007 ▶); Habeeb et al. (2001 ▶); Hashimoto et al. (2002 ▶); Ranatunge et al. (2004 ▶); Singh et al. (2005 ▶); Elzein et al. (2006 ▶). For previous reports on the diazotization of heterocyclic amines, see: Abdel-Aziz et al. (2008 ▶); Hamdy et al. (2007 ▶); Dawood et al. (2005 ▶); Farag et al. (2004 ▶). For graph-set notation, see: Bernstein et al. (1995 ▶).

Experimental

Crystal data

C17H16N6O2S M = 368.42 Monoclinic, a = 8.0672 (5) Å b = 10.6460 (7) Å c = 20.5892 (13) Å β = 90.332 (1)° V = 1768.24 (19) Å3 Z = 4 Mo Kα radiation μ = 0.21 mm−1 T = 296 K 0.47 × 0.22 × 0.13 mm

Data collection

Bruker APEXII DUO CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ▶) T min = 0.908, T max = 0.974 33610 measured reflections 4782 independent reflections 3518 reflections with I > 2σ(I) R int = 0.029

Refinement

R[F 2 > 2σ(F 2)] = 0.063 wR(F 2) = 0.219 S = 1.06 4782 reflections 238 parameters H-atom parameters constrained Δρmax = 0.61 e Å−3 Δρmin = −0.68 e Å−3 Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: SAINT (Bruker, 2009 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 ▶). Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S1600536811028911/is2753sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536811028911/is2753Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536811028911/is2753Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C17H16N6O2SF(000) = 768
Mr = 368.42Dx = 1.384 Mg m3
Monoclinic, P21/nMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ynCell parameters from 8773 reflections
a = 8.0672 (5) Åθ = 2.7–28.9°
b = 10.6460 (7) ŵ = 0.21 mm1
c = 20.5892 (13) ÅT = 296 K
β = 90.332 (1)°Block, yellow
V = 1768.24 (19) Å30.47 × 0.22 × 0.13 mm
Z = 4
Bruker APEXII DUO CCD area-detector diffractometer4782 independent reflections
Radiation source: fine-focus sealed tube3518 reflections with I > 2σ(I)
graphiteRint = 0.029
φ and ω scansθmax = 29.2°, θmin = 2.0°
Absorption correction: multi-scan (SADABS; Bruker, 2009)h = −11→11
Tmin = 0.908, Tmax = 0.974k = −14→14
33610 measured reflectionsl = −28→28
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.063Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.219H-atom parameters constrained
S = 1.06w = 1/[σ2(Fo2) + (0.1182P)2 + 0.809P] where P = (Fo2 + 2Fc2)/3
4782 reflections(Δ/σ)max = 0.001
238 parametersΔρmax = 0.61 e Å3
0 restraintsΔρmin = −0.68 e Å3
Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
O10.3443 (3)0.6604 (2)0.08593 (9)0.0832 (7)
O20.4554 (3)0.80464 (18)0.01904 (9)0.0674 (5)
N1−0.0513 (2)0.07181 (16)0.08467 (9)0.0443 (4)
N20.0682 (3)0.16420 (17)−0.01066 (9)0.0527 (5)
H1N20.07090.1009−0.03920.063*
N30.1472 (3)0.27295 (17)−0.02803 (9)0.0514 (5)
N40.2184 (2)0.46227 (16)0.02614 (8)0.0447 (4)
H1N40.22990.50140.06170.054*
N50.2772 (2)0.51079 (17)−0.02755 (8)0.0441 (4)
N60.4563 (4)0.7030 (3)−0.13610 (14)0.0921 (9)
C10.0215 (3)0.16591 (18)0.05219 (9)0.0413 (4)
C2−0.0843 (3)0.09562 (19)0.14668 (10)0.0418 (4)
C3−0.0472 (2)0.21163 (18)0.17806 (10)0.0407 (4)
C40.0297 (2)0.30706 (17)0.14358 (9)0.0370 (4)
C50.0674 (2)0.28297 (17)0.07806 (9)0.0375 (4)
C60.1458 (3)0.34311 (19)0.02462 (9)0.0419 (4)
C70.3502 (3)0.6208 (2)−0.02605 (10)0.0465 (5)
C80.4084 (3)0.6659 (3)−0.08754 (13)0.0588 (6)
C90.3807 (3)0.6957 (2)0.03246 (12)0.0554 (6)
C100.4980 (4)0.8842 (3)0.07369 (16)0.0752 (8)
H10A0.59390.93500.06310.090*
H10B0.52580.83260.11100.090*
C110.3568 (6)0.9662 (4)0.0894 (2)0.1057 (13)
H11A0.38781.02240.12380.158*
H11B0.26460.91580.10290.158*
H11C0.32611.01400.05160.158*
C120.0656 (2)0.43206 (17)0.17233 (9)0.0385 (4)
S10.21437 (12)0.45313 (7)0.23040 (5)0.0874 (4)
C13−0.0232 (3)0.54559 (17)0.16053 (11)0.0471 (5)
H13A−0.11180.55520.13190.056*
C140.0476 (3)0.6427 (2)0.20046 (14)0.0605 (7)
H14A0.01100.72550.19890.073*
C150.1673 (4)0.6062 (3)0.23924 (14)0.0674 (7)
H15A0.22070.65910.26860.081*
C16−0.1660 (4)−0.0089 (2)0.18327 (13)0.0591 (6)
H16A−0.1719−0.08230.15630.089*
H16B−0.27590.01610.19540.089*
H16C−0.1024−0.02750.22170.089*
C17−0.1005 (4)0.2290 (2)0.24741 (12)0.0590 (6)
H17A−0.07520.31300.26120.089*
H17B−0.04260.17020.27460.089*
H17C−0.21770.21490.25060.089*
U11U22U33U12U13U23
O10.1284 (19)0.0709 (13)0.0503 (10)−0.0409 (13)0.0105 (11)−0.0096 (9)
O20.0854 (13)0.0548 (10)0.0619 (11)−0.0234 (9)−0.0050 (9)0.0013 (8)
N10.0605 (10)0.0309 (8)0.0415 (9)−0.0040 (7)−0.0020 (7)−0.0093 (6)
N20.0854 (14)0.0356 (9)0.0372 (9)−0.0096 (9)0.0032 (9)−0.0098 (7)
N30.0774 (13)0.0385 (9)0.0384 (9)−0.0054 (9)0.0012 (8)−0.0044 (7)
N40.0599 (11)0.0372 (8)0.0371 (8)−0.0072 (7)0.0009 (7)−0.0031 (6)
N50.0515 (10)0.0407 (9)0.0401 (9)−0.0024 (7)−0.0033 (7)0.0010 (7)
N60.120 (2)0.094 (2)0.0626 (15)−0.0126 (17)0.0142 (15)0.0220 (14)
C10.0559 (11)0.0300 (9)0.0381 (9)−0.0006 (8)−0.0031 (8)−0.0071 (7)
C20.0488 (10)0.0325 (9)0.0441 (10)−0.0020 (8)0.0013 (8)−0.0064 (7)
C30.0467 (10)0.0355 (9)0.0400 (9)0.0001 (8)0.0033 (8)−0.0090 (7)
C40.0420 (9)0.0296 (8)0.0394 (9)0.0022 (7)−0.0028 (7)−0.0094 (7)
C50.0460 (10)0.0285 (8)0.0379 (9)0.0012 (7)−0.0033 (7)−0.0060 (7)
C60.0539 (11)0.0341 (9)0.0375 (9)−0.0010 (8)−0.0024 (8)−0.0036 (7)
C70.0519 (11)0.0434 (11)0.0443 (11)−0.0040 (9)−0.0033 (9)0.0029 (8)
C80.0656 (15)0.0572 (14)0.0536 (13)−0.0080 (12)−0.0014 (11)0.0084 (11)
C90.0665 (14)0.0486 (12)0.0512 (12)−0.0124 (11)0.0006 (10)−0.0013 (10)
C100.088 (2)0.0700 (18)0.0674 (17)−0.0241 (16)−0.0069 (15)−0.0054 (14)
C110.123 (3)0.104 (3)0.090 (3)0.005 (3)0.022 (2)−0.018 (2)
C120.0471 (10)0.0322 (9)0.0362 (9)−0.0007 (7)−0.0024 (7)−0.0092 (7)
S10.1022 (6)0.0517 (4)0.1075 (7)0.0073 (4)−0.0565 (5)−0.0211 (4)
C130.0628 (13)0.0254 (8)0.0529 (12)−0.0027 (8)−0.0138 (10)−0.0069 (8)
C140.0720 (16)0.0301 (10)0.0795 (17)0.0007 (10)0.0077 (13)−0.0153 (10)
C150.0914 (19)0.0490 (13)0.0617 (15)−0.0171 (13)−0.0097 (14)−0.0215 (11)
C160.0800 (16)0.0428 (11)0.0544 (13)−0.0172 (11)0.0066 (12)−0.0038 (10)
C170.0762 (16)0.0506 (13)0.0504 (12)−0.0084 (12)0.0185 (11)−0.0156 (10)
O1—C91.202 (3)C7—C81.436 (3)
O2—C91.337 (3)C7—C91.464 (3)
O2—C101.448 (3)C10—C111.472 (5)
N1—C21.330 (3)C10—H10A0.9700
N1—C11.342 (3)C10—H10B0.9700
N2—C11.350 (3)C11—H11A0.9600
N2—N31.370 (3)C11—H11B0.9600
N2—H1N20.8953C11—H11C0.9600
N3—C61.317 (3)C12—C131.425 (3)
N4—N51.312 (2)C12—S11.704 (2)
N4—C61.398 (3)S1—C151.683 (3)
N4—H1N40.8475C13—C141.438 (3)
N5—C71.311 (3)C13—H13A0.9300
N6—C81.144 (3)C14—C151.309 (4)
C1—C51.404 (2)C14—H14A0.9300
C2—C31.425 (3)C15—H15A0.9300
C2—C161.498 (3)C16—H16A0.9600
C3—C41.388 (3)C16—H16B0.9600
C3—C171.505 (3)C16—H16C0.9600
C4—C51.408 (3)C17—H17A0.9600
C4—C121.484 (2)C17—H17B0.9600
C5—C61.424 (3)C17—H17C0.9600
C9—O2—C10116.9 (2)O2—C10—H10A109.7
C2—N1—C1115.27 (17)C11—C10—H10A109.7
C1—N2—N3111.82 (16)O2—C10—H10B109.7
C1—N2—H1N2130.4C11—C10—H10B109.7
N3—N2—H1N2116.9H10A—C10—H10B108.2
C6—N3—N2104.96 (17)C10—C11—H11A109.5
N5—N4—C6119.50 (17)C10—C11—H11B109.5
N5—N4—H1N4119.8H11A—C11—H11B109.5
C6—N4—H1N4120.6C10—C11—H11C109.5
C7—N5—N4119.77 (18)H11A—C11—H11C109.5
N1—C1—N2126.38 (17)H11B—C11—H11C109.5
N1—C1—C5126.08 (18)C13—C12—C4126.55 (17)
N2—C1—C5107.51 (18)C13—C12—S1111.06 (14)
N1—C2—C3123.90 (19)C4—C12—S1122.20 (15)
N1—C2—C16115.61 (18)C15—S1—C1292.58 (12)
C3—C2—C16120.49 (19)C12—C13—C14108.4 (2)
C4—C3—C2119.73 (18)C12—C13—H13A125.8
C4—C3—C17121.76 (18)C14—C13—H13A125.8
C2—C3—C17118.46 (19)C15—C14—C13115.1 (2)
C3—C4—C5117.16 (16)C15—C14—H14A122.5
C3—C4—C12122.62 (17)C13—C14—H14A122.5
C5—C4—C12120.17 (17)C14—C15—S1112.84 (18)
C1—C5—C4117.84 (18)C14—C15—H15A123.6
C1—C5—C6102.90 (16)S1—C15—H15A123.6
C4—C5—C6139.26 (18)C2—C16—H16A109.5
N3—C6—N4121.85 (19)C2—C16—H16B109.5
N3—C6—C5112.78 (18)H16A—C16—H16B109.5
N4—C6—C5125.35 (17)C2—C16—H16C109.5
N5—C7—C8115.3 (2)H16A—C16—H16C109.5
N5—C7—C9125.4 (2)H16B—C16—H16C109.5
C8—C7—C9119.3 (2)C3—C17—H17A109.5
N6—C8—C7179.0 (3)C3—C17—H17B109.5
O1—C9—O2125.0 (2)H17A—C17—H17B109.5
O1—C9—C7122.8 (2)C3—C17—H17C109.5
O2—C9—C7112.1 (2)H17A—C17—H17C109.5
O2—C10—C11109.7 (3)H17B—C17—H17C109.5
C1—N2—N3—C6−1.2 (3)N5—N4—C6—N36.0 (3)
C6—N4—N5—C7−177.88 (19)N5—N4—C6—C5−175.59 (19)
C2—N1—C1—N2179.4 (2)C1—C5—C6—N30.5 (2)
C2—N1—C1—C51.5 (3)C4—C5—C6—N3179.5 (2)
N3—N2—C1—N1−176.7 (2)C1—C5—C6—N4−178.0 (2)
N3—N2—C1—C51.6 (3)C4—C5—C6—N41.0 (4)
C1—N1—C2—C30.1 (3)N4—N5—C7—C8−179.3 (2)
C1—N1—C2—C16179.9 (2)N4—N5—C7—C93.1 (4)
N1—C2—C3—C4−0.8 (3)C10—O2—C9—O11.3 (4)
C16—C2—C3—C4179.4 (2)C10—O2—C9—C7−177.5 (2)
N1—C2—C3—C17176.4 (2)N5—C7—C9—O12.0 (4)
C16—C2—C3—C17−3.4 (3)C8—C7—C9—O1−175.5 (3)
C2—C3—C4—C50.0 (3)N5—C7—C9—O2−179.2 (2)
C17—C3—C4—C5−177.1 (2)C8—C7—C9—O23.3 (3)
C2—C3—C4—C12177.37 (18)C9—O2—C10—C11−87.7 (3)
C17—C3—C4—C120.3 (3)C3—C4—C12—C13−103.8 (3)
N1—C1—C5—C4−2.2 (3)C5—C4—C12—C1373.5 (3)
N2—C1—C5—C4179.51 (18)C3—C4—C12—S170.8 (2)
N1—C1—C5—C6177.1 (2)C5—C4—C12—S1−111.9 (2)
N2—C1—C5—C6−1.2 (2)C13—C12—S1—C15−0.9 (2)
C3—C4—C5—C11.3 (3)C4—C12—S1—C15−176.20 (19)
C12—C4—C5—C1−176.08 (18)C4—C12—C13—C14177.2 (2)
C3—C4—C5—C6−177.6 (2)S1—C12—C13—C142.2 (3)
C12—C4—C5—C65.0 (4)C12—C13—C14—C15−2.9 (3)
N2—N3—C6—N4178.99 (19)C13—C14—C15—S12.3 (4)
N2—N3—C6—C50.4 (3)C12—S1—C15—C14−0.8 (3)
D—H···AD—HH···AD···AD—H···A
N2—H1N2···N1i0.892.072.941 (3)165
N4—H1N4···O10.851.992.642 (3)133
C13—H13A···N5ii0.932.623.463 (3)151
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N2—H1N2⋯N1i0.892.072.941 (3)165
N4—H1N4⋯O10.851.992.642 (3)133
C13—H13A⋯N5ii0.932.623.463 (3)151

Symmetry codes: (i) ; (ii) .

  7 in total

1.  Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists.

Authors:  Elfatih Elzein; Rao Kalla; Xiaofen Li; Thao Perry; Eric Parkhill; Venkata Palle; Vaibahv Varkhedkar; Art Gimbel; Dewan Zeng; David Lustig; Kwan Leung; Jeff Zablocki
Journal:  Bioorg Med Chem Lett       Date:  2005-11-04       Impact factor: 2.823

2.  Synthesis and SAR/3D-QSAR studies on the COX-2 inhibitory activity of 1,5-diarylpyrazoles to validate the modified pharmacophore.

Authors:  Sunil K Singh; V Saibaba; K Srinivasa Rao; P Ganapati Reddy; Pankaj R Daga; S Abdul Rajjak; Parimal Misra; Y Koteswar Rao
Journal:  Eur J Med Chem       Date:  2005-06-14       Impact factor: 6.514

3.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

4.  Design and synthesis of celecoxib and rofecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of sulfonamide and methylsulfonyl pharmacophores by an azido bioisostere.

Authors:  A G Habeeb; P N Praveen Rao; E E Knaus
Journal:  J Med Chem       Date:  2001-08-30       Impact factor: 7.446

5.  4-(4-cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as selective cyclooxygenase-2 inhibitors: enhancement of the selectivity by introduction of a fluorine atom and identification of a potent, highly selective, and orally active COX-2 inhibitor JTE-522(1).

Authors:  Hiromasa Hashimoto; Katsuaki Imamura; Jun-ichi Haruta; Korekiyo Wakitani
Journal:  J Med Chem       Date:  2002-03-28       Impact factor: 7.446

6.  3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.

Authors:  Ramani R Ranatunge; Richard A Earl; David S Garvey; David R Janero; L Gordon Letts; Allison M Martino; Madhavi G Murty; Stewart K Richardson; David J Schwalb; Delano V Young; Irina S Zemtseva
Journal:  Bioorg Med Chem Lett       Date:  2004-12-20       Impact factor: 2.823

7.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  7 in total
  2 in total

1.  5,6-Dimethyl-4-(thio-phen-2-yl)-1H-pyrazolo-[3,4-b]pyridin-3-amine.

Authors:  Hatem A Abdel-Aziz; Khalid A Al-Rashood; Hazem A Ghabbour; Suchada Chantrapromma; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-04

2.  Two isostructural 3-(5-ar-yloxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-1-(thio-phen-2-yl)prop-2-en-1-ones: disorder and supra-molecular assembly.

Authors:  Mohammed A E Shaibah; Hemmige S Yathirajan; Nagaraj Manju; Balakrishna Kalluraya; Ravindranath S Rathore; Christopher Glidewell
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2020-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.